Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LIFE | AMGN | GILD | CELG | BIIB |
| Company | Atyr Pharma Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.8600 | 333.93 | 83.37 | 108.01 | 198.13 |
| High | 1.9500 | 339.00 | 84.52 | 108.59 | 199.78 |
| Low | 1.8200 | 331.00 | 82.76 | 107.27 | 196.81 |
| Last | 1.9000 | 333.58 | 83.90 | 108.24 | 197.58 |
| Change | +0.0500 | +0.78 | +0.85 | +0.11 | -0.63 |
| % Change | +2.70% | +0.23% | +1.02% | +0.10% | -0.32% |
| Volume | 269,400 | 906,463 | 6,723,572 | 191,230,496 | 443,604 |
| 20-Day Average Volume | 540,290 | 1,709,301 | 6,297,032 | 16,188,930 | 789,486 |
| Previous Close | 1.8500 | 332.80 | 83.05 | 108.13 | 198.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8177 | 329.29 | 79.64 | 108.17 | 201.85 |
| 20-Day Raw Stochastic | 58.70% | 75.16% | 90.58% | 63.25% | 35.98% |
| 20-Day Relative Strength | 56.18% | 56.03% | 71.94% | 64.69% | 39.72% |
| Weighted Alpha | -6.86 | +26.01 | +18.32 | +46.30 | -23.58 |
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | 100% Buy | 100% Sell |
| Previous Opinion | 96% Buy | 88% Buy | 88% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 8% Buy | 72% Buy | 40% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.15% since 05/28/24 | +1.18% since 09/11/24 | +3.71% since 09/11/24 | -1.97% since 11/13/19 | -0.66% since 09/11/24 |
| Low | 1.6500 on 05/30/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 192.25 on 09/13/24 |
| High | 1.9500 on 06/04/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 110.53 on 11/14/19 | 202.79 on 09/17/24 |
| 1-Month | |||||
| %Chg | +18.01% since 05/03/24 | +3.87% since 08/16/24 | +13.77% since 08/16/24 | +5.14% since 10/18/19 | -2.05% since 08/16/24 |
| Low | 1.5901 on 05/06/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 102.40 on 10/21/19 | 192.25 on 09/13/24 |
| High | 2.0900 on 05/21/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +6.15% since 03/04/24 | +9.12% since 06/18/24 | +32.92% since 06/18/24 | +13.63% since 08/20/19 | -11.57% since 06/18/24 |
| Low | 1.5400 on 05/02/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 192.25 on 09/13/24 |
| High | 2.1500 on 03/20/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +50.20% since 12/04/23 | +23.25% since 03/18/24 | +14.58% since 03/18/24 | +14.14% since 05/20/19 | -9.86% since 03/18/24 |
| Low | 1.1400 on 12/11/23 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 2.1500 on 03/20/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 131,121 | 178,525,568 | 103,468,096 | 77,035,920 | 28,858,782 |
| Shares Outstanding, K | 69,011 | 536,435 | 1,245,853 | 711,714 | 145,597 |
| Annual Sales | 350,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -50,390,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 240,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,464,900,000 |
| Last Quarter Net Income | -15,490,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | 583,600,000 |
| 60-Month Beta | 1.19 | 0.61 | 0.18 | 1.41 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 05/02/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 5.28 on 08/01/24 |
| Latest Earnings Date | 05/14/24 | 10/29/24 | 11/05/24 | 10/31/19 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.02 | 17.69 | 10.99 | 12.27 |